Wednesday, April 21, 2021

Inspired by COVID vaccine roll-out, poultry business trials E.coli vaccine to safeguard birds

Inspired by the UK government’s COVID-19 vaccine programme, Banham Poultry, one of the nation’s largest poultry businesses, is trialling a new E.coli vaccine to safeguard its birds.

In a UK first, Banham Poultry has joined forces with pharmaceutical company, Zoetis, and poultry veterinary consultants, Crowshall Veterinary Services, in trialling a new vaccine, Poulvac E.coli.

The vaccine is being administered to day old chicks along with other vaccines in the hatchery, and sets out to protect the chickens against E.coli, which can cause disease and mortality in birds, leading to poorer welfare, and poor productivity as well as increased antibiotic use.

It is anticipated that this vaccine will prevent the disease associated with E.coli bacteria by providing the birds with immunity.

This trial has already been implemented, and more than 1.6 million birds will receive this Government approved vaccine.

If the trial is successful, Banham Poultry will roll out the programme across its entire farming base.

Banham Poultry Managing Director Blaine Van Rensburg said: “The poultry industry is a success story in its significant achievement in reducing antibiotic usage over the past five years, and the drive continues.

“The world is changing, and we are all acutely aware, in the face of COVID-19, how vaccination is the cornerstone of disease control. We are now taking the same approach in protecting the welfare of our birds.

“The poultry industry can be proud of the essential work that it has done in feeding the nation through the recent COVID-19 crises, but now more than ever food security and safety are key to the health of the nation.

“Livestock face challenges too, and disease threats always exist, and the team here is evaluating new interventions to further protect the health of our stock and the quality of the products we produce.”

A message from the Editor:

Thank you for reading this story on our news site - please take a moment to read this important message:

As you know, our aim is to bring you, the reader, an editorially led news site and magazine but journalism costs money and we rely on advertising, print and digital revenues to help to support them.

With the Covid-19 pandemic having a major impact on our industry as a whole, the advertising revenues we normally receive, which helps us cover the cost of our journalists and this website, have been drastically affected.

As such we need your help. If you can support our news sites/magazines with either a small donation of even £1, or a subscription to our magazine, which costs just £31.50 per year, (inc p&P and mailed direct to your door) your generosity will help us weather the storm and continue in our quest to deliver quality journalism.

As a subscriber, you will have unlimited access to our web site and magazine. You'll also be offered VIP invitations to our events, preferential rates to all our awards and get access to exclusive newsletters and content.

Just click here to subscribe and in the meantime may I wish you the very best.

Latest news

Related news

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.